68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy.

Francesco CeciPaolo CastellucciTiziano GrazianiAndrea FarolfiCristina FontiFilippo LodiStefano Fanti

Published in: European journal of nuclear medicine and molecular imaging (2018)

Our data confirmed the efficacy of 68Ga-PSMA-11 PET/CT for detecting local vs systemic disease in PCa patients presenting PSA failure after radical therapy. Furthermore, 68Ga-PSMA-11 PET/CT detection rate is different depending on the clinical stage of BCR, and this information should be taken into consideration by referring physicians.

Keyphrases

pet ct
prostate cancer
radical prostatectomy
positron emission tomography
end stage renal disease
newly diagnosed
chronic kidney disease
primary care
prognostic factors
stem cells
patient reported outcomes
health information
bone marrow
artificial intelligence